Anterix (ATEX)
(Real Time Quote from BATS)
$37.10 USD
-0.99 (-2.60%)
Updated Aug 26, 2024 01:08 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Balance Sheet
Fiscal Year End for Anterix Inc falls in the month of March.
All items in Millions except Per Share data.
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 61 | 43 | 106 | 118 | 137 |
Receivables | 9 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 4 | 16 | 10 | 4 | 5 |
Total Current Assets | 73 | 59 | 116 | 121 | 142 |
Net Property & Equipment | 2 | 4 | 3 | 4 | 7 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 237 | 202 | 151 | 122 | 112 |
Deposits & Other Assets | 9 | 10 | 4 | 1 | 0 |
Total Assets | 325 | 279 | 278 | 253 | 267 |
Liabilities & Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 9 | 7 | 7 | 6 | 6 |
Current Portion Long-Term Debt | 0 | 1 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 7 | 23 | 1 | 1 | 1 |
Total Current Liabilities | 18 | 32 | 10 | 9 | 9 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 122 | 63 | 57 | 5 | 6 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 20 | 1 | 21 | 21 | 1 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 164 | 99 | 92 | 41 | 22 |
Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 533 | 518 | 500 | 473 | 451 |
Retained Earnings | -372 | -338 | -314 | -260 | -206 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 161 | 180 | 186 | 213 | 245 |
Total Liabilities & Shareholder's Equity | 325 | 279 | 278 | 253 | 267 |
Total Common Equity | 161 | 180 | 186 | 213 | 245 |
Shares Outstanding | 18.50 | 18.80 | 18.30 | 17.50 | 14.80 |
Book Value Per Share | 8.70 | 9.56 | 10.18 | 12.14 | 16.56 |
Fiscal Year End for Anterix Inc falls in the month of March.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 52 | 61 | 62 | 49 | 29 |
Receivables | 11 | 9 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 3 | 4 | 16 | 14 | 15 |
Total Current Assets | 66 | 73 | 78 | 62 | 44 |
Net Property & Equipment | 2 | 2 | 2 | 2 | 3 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 240 | 237 | 214 | 198 | 216 |
Deposits & Other Assets | 9 | 9 | 23 | 15 | 14 |
Total Assets | 321 | 325 | 321 | 280 | 279 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 8 | 9 | 8 | 7 | 8 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 7 | 7 | 7 | 7 | 23 |
Total Current Liabilities | 17 | 18 | 17 | 15 | 33 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 122 | 122 | 107 | 81 | 62 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 30 | 20 | 5 | 1 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 172 | 164 | 149 | 104 | 98 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 539 | 533 | 529 | 525 | 522 |
Retained Earnings | -390 | -372 | -357 | -349 | -340 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 149 | 161 | 172 | 176 | 181 |
Total Liabilities & Shareholder's Equity | 321 | 325 | 321 | 280 | 279 |
Total Common Equity | 149 | 161 | 172 | 176 | 181 |
Shares Outstanding | 18.50 | 18.50 | 18.70 | 19.00 | 19.00 |
Book Value Per Share | 8.04 | 8.70 | 9.21 | 9.27 | 9.54 |